Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Correction

This article was originally published in The Tan Sheet

Executive Summary

In the article "Senate Puts FDA On Notice To Solve FDAAA Sec. 912 Puzzle" (1"The Tan Sheet" July 13, 2009), we should not have stated that a citizen petition relating to stevia-based sweeteners in food products "is rendered irrelevant" by FDA's letters of no objection to marketers of stevia products. The letters state FDA's decision does not consider whether the products in question might violate Sec. 912 of FDAAA. "The Tan Sheet" regrets the misstatement

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS103125

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel